Brittany Avin McKelvey, Senior Director of Regulatory Policy at LUNGevity Foundation, shared on LinkedIn:
“I’m looking forward to attending the American Association for Cancer Research Drug Discovery and Development (AACRD3) meeting this week! On July 23rd, I’ll be participating in a panel discussion on regulatory policy trends impacting oncology, as well as presenting our work at LUNGevity Foundation on the interpretation of duration of response endpoints in lung cancer trials.”
Other articles about LUNGevity Foundation on OncoDaily.